-

Scott+Scott Attorneys at Law LLP Continues to Investigate Regeneron Pharmaceuticals, Inc.’s Directors and Officers for Breach of Fiduciary Duty (REGN)

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a national securities and consumer rights litigation firm, continues to investigate whether certain directors and officers of Regeneron Pharmaceuticals, Inc. (“Regeneron”) (NASDAQ: REGN) breached their fiduciary duties to Regeneron and its shareholders. If you are a Regeneron shareholder, you are encouraged to contact attorney Joe Pettigrew toll-free at (844) 818-6982 or jpettigrew@scott-scott.com.

Scott+Scott is investigating whether Regeneron’s board of directors or senior management failed to manage Regeneron in an acceptable manner, in breach of their fiduciary duties to Regeneron, and whether Regeneron has suffered damages as a result.

In January 2017, Regeneron received a subpoena from the U.S. Attorney’s Office for the District of Massachusetts regarding violations of federal anti-kickback statutes concerning use of patient-assistance funds to encourage doctors to prescribe certain of Regeneron’s drugs over less-expensive competitors.

In September 2019, Regeneron received a civil investigative demand from the U.S. Department of Justice pursuant to the federal False Claims Act investigating separate violations of federal anti-kickback statutes.

On June 24, 2020, federal prosecutors in Massachusetts filed suit against Regeneron, claiming violations of federal anti-kickback statutes.

What You Can Do

If you are a Regeneron shareholder, you may have legal claims against Regeneron’s directors and officers. If you wish to discuss this investigation, or have questions about this notice or your legal rights, please contact attorney Joe Pettigrew toll-free at (844) 818-6982 or jpettigrew@scott-scott.com.

About Scott+Scott Attorneys at Law LLP

Scott+Scott has significant experience in prosecuting major securities, antitrust, and consumer rights actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Amsterdam, Connecticut, California, Ohio, and Virginia.

Attorney Advertising

Contacts

Joe Pettigrew
Scott+Scott Attorneys at Law LLP
230 Park Avenue, 17th Floor, NY, New York 10169
(844) 818-6982
jpettigrew@scott-scott.com

Scott+Scott Attorneys at Law LLP

NASDAQ:REGN

Release Summary
Scott+Scott Attorneys at Law LLP Continues to Investigate Regeneron Pharma, Inc.’s Directors and Officers for Breach of Fiduciary Duty (REGN)
Release Versions

Contacts

Joe Pettigrew
Scott+Scott Attorneys at Law LLP
230 Park Avenue, 17th Floor, NY, New York 10169
(844) 818-6982
jpettigrew@scott-scott.com

More News From Scott+Scott Attorneys at Law LLP

DRAFTKINGS INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates DraftKings Inc.’s Directors and Officers for Breach of Fiduciary Duties – DKNG

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of DraftKings Inc. (NASDAQ: DKNG) failed to manage DraftKings in an acceptable manner, breaching their fiduciary duties to DraftKings, and whether DraftKings and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know: On December 8, 2023, consumers filed a lawsuit against...

JPMORGAN CHASE & CO. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates JPMorgan Chase & Co.’s Directors and Officers for Breach of Fiduciary Duties – JPM

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of JPMorgan Chase & Co. (NYSE: JPM) failed to manage JPMorgan Chase in an acceptable manner, breaching their fiduciary duties to JPMorgan Chase, and whether JPMorgan Chase and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know: On February 26, 2026, dozens of inst...

Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation Into Via Transportation, Inc. (NYSE: VIA)

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder and consumer rights litigation firm, alerts investors of its investigation into Via Transportation, Inc. (“Via Transportation” or the “Company”) (NYSE: VIA) concerning the Company’s possible violations of the federal securities laws. CLICK HERE TO RECEIVE ADDITIONAL INFORMATION ABOUT THIS POTENTIAL CLASS ACTION Via Transportation went public on the NYSE in September 2025 at $46 per share. The Company purp...
Back to Newsroom